{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:51:22Z","timestamp":1794408682354,"version":"4.9.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T00:00:00Z","timestamp":1596499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Phenylketonuria (PKU) is an autosomal recessive inborn error of phenylalanine metabolism caused by deficiency in the enzyme phenylalanine hydroxylase that converts phenylalanine into tyrosine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>In 2017 the first European PKU Guidelines were published. These guidelines contained evidence based and\/or expert opinion recommendations regarding diagnosis, treatment and care for patients with PKU of all ages. This manuscript is a supplement containing the practical application of the dietary treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This handbook can support dietitians, nutritionists and physicians in starting, adjusting and maintaining dietary treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-020-01391-y","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T14:53:21Z","timestamp":1593528801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":213,"title":["PKU dietary handbook to accompany PKU guidelines"],"prefix":"10.1186","volume":"15","author":[{"given":"A.","family":"MacDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-4833","authenticated-orcid":false,"given":"A. M. J.","family":"van Wegberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ahring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Beblo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"B\u00e9langer-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Campistol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Feillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gi\u017cewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. C.","family":"Huijbregts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Muntau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Trefz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.","family":"van Spronsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,4]]},"reference":[{"issue":"1","key":"1391_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13023-017-0685-2","volume":"12","author":"AMJ van Wegberg","year":"2017","unstructured":"van Wegberg AMJ, MacDonald A, Ahring K, Belanger-Quintana A, Blau N, Bosch AM, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162.","journal-title":"Orphanet J Rare Dis"},{"key":"1391_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/8904_2016_12","volume":"34","author":"A Araujo","year":"2017","unstructured":"Araujo A, Araujo WMC, Marquez UML, Akutsu R, Nakano EY. Table of phenylalanine content of foods: comparative analysis of data compiled in food composition tables. JIMD Rep. 2017;34:87\u201396.","journal-title":"JIMD Rep"},{"key":"1391_CR3","volume-title":"A list of phenylalanine to protein ratios for common foods","author":"J Kim","year":"2014","unstructured":"Kim J, Boutin M. A list of phenylalanine to protein ratios for common foods; 2014."},{"issue":"3","key":"1391_CR4","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-277X.2006.00696.x","volume":"19","author":"E Weetch","year":"2006","unstructured":"Weetch E, Macdonald A. The determination of phenylalanine content of foods suitable for phenylketonuria. J Hum Nutr Diet. 2006;19(3):229\u201336.","journal-title":"J Hum Nutr Diet"},{"key":"1391_CR5","first-page":"391","volume-title":"Clinical paediatrics dietetics","author":"A MacDonald","year":"2015","unstructured":"MacDonald A, White F. Amino acid disorders. In: Shaw V, editor. Clinical paediatrics dietetics. Chichester: Wiley Blackwell; 2015. p. 391\u2013456."},{"issue":"2","key":"1391_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jimd.12173","volume":"43","author":"RAF Evers","year":"2019","unstructured":"Evers RAF, van Wegberg AMJ, Anjema K, Lubout CMA, van Dam E, van Vliet D, et al. The first European guidelines on phenylketonuria: usefulness and implications for BH4 responsiveness testing. J Inherit Metab Dis. 2019;43(2):244\u201350.","journal-title":"J Inherit Metab Dis"},{"key":"1391_CR7","unstructured":"WHO\/FAO\/UNU. Protein and amino acid requirements in human nutrition. Report of a joint WHO\/FAO\/UNU expert consultation WHO Technical Report Series 935: United Nations University; 2007."},{"issue":"4","key":"1391_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ymgme.2009.07.016","volume":"98","author":"EL MacLeod","year":"2009","unstructured":"MacLeod EL, Gleason ST, van Calcar SC, Ney DM. Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes. Mol Genet Metab. 2009;98(4):331\u20137.","journal-title":"Mol Genet Metab"},{"key":"1391_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ymgmr.2018.11.003","volume":"18","author":"A Pinto","year":"2019","unstructured":"Pinto A, Adams S, Ahring K, Allen H, Almeida MF, Garcia-Arenas D, et al. Weaning practices in phenylketonuria vary between health professionals in Europe. Mol Genet Metab Rep. 2019;18:39\u201344.","journal-title":"Mol Genet Metab Rep."},{"issue":"2","key":"1391_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000324924","volume":"58","author":"M van Rijn","year":"2011","unstructured":"van Rijn M, Hoeksma M, Sauer PJ, Modderman P, Reijngoud DJ, van Spronsen FJ. Adult patients with well-controlled phenylketonuria tolerate incidental additional intake of phenylalanine. Ann Nutr Metab. 2011;58(2):94\u2013100.","journal-title":"Ann Nutr Metab."},{"issue":"1","key":"1391_CR11","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-018-0950-z","volume":"14","author":"S Evans","year":"2019","unstructured":"British Inherited Metabolic Diseases Group, Evans S, Ford S, Adam S, Adams S, Ash J, et al. Development of national consensus statements on food labelling interpretation and protein allocation in a low phenylalanine diet for PKU. Orphanet J Rare Dis. 2019;14(1):2.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"1391_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ymgme.2015.03.006","volume":"115","author":"A Aguiar","year":"2015","unstructured":"Aguiar A, Ahring K, Almeida MF, Assoun M, Belanger Quintana A, Bigot S, et al. Practices in prescribing protein substitutes for PKU in Europe: no uniformity of approach. Mol Genet Metab. 2015;115(1):17\u201322.","journal-title":"Mol Genet Metab"},{"key":"1391_CR13","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1136\/adc.2005.084285","volume":"91","author":"A MacDonald","year":"2006","unstructured":"MacDonald A, Chakrapani A, Hendriksz C, Daly A, Davies P, Asplin D, et al. Protein substitute dosage in PKU: how much do young patients need? Arch Dis Child. 2006;91:588\u201393.","journal-title":"Arch Dis Child"},{"issue":"4","key":"1391_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1023\/A:1025186217369","volume":"26","author":"A MacDonald","year":"2003","unstructured":"MacDonald A, Rylance G, Davies P, Asplin D, Hall SK, Booth IW. Administration of protein substitute and quality of control in phenylketonuria: a randomized study. J Inherit Metab Dis. 2003;26(4):319\u201326.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"1391_CR15","first-page":"354","volume":"2","author":"HN Munro","year":"1953","unstructured":"Munro HN, Thomson WS. Influence of glucose on amino acid metabolism. Metabolism. 1953;2(4):354\u201361.","journal-title":"Metabolism."},{"issue":"11","key":"1391_CR16","doi-asserted-by":"publisher","first-page":"E1794","DOI":"10.3390\/nu10111794","volume":"10","author":"MJ Pena","year":"2018","unstructured":"Pena MJ, Pinto A, Daly A, MacDonald A, Azevedo L, Rocha JC, et al. The use of glycomacropeptide in patients with phenylketonuria: a systematic review and meta-analysis. Nutrients. 2018;10(11):E1794.","journal-title":"Nutrients"},{"issue":"3","key":"1391_CR17","doi-asserted-by":"publisher","first-page":"E520","DOI":"10.3390\/nu11030520","volume":"11","author":"A Daly","year":"2019","unstructured":"Daly A, Evans S, Chahal S, Santra S, Pinto A, Gingell C, et al. The effect of glycomacropeptide versus amino acids on phenylalanine and tyrosine variability over 24 hours in children with PKU: a randomized controlled trial. Nutrients. 2019;11(3):E520.","journal-title":"Nutrients"},{"issue":"4","key":"1391_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/jhn.12438","volume":"30","author":"A Daly","year":"2017","unstructured":"Daly A, Evans S, Chahal S, Santra S, MacDonald A. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control? J Hum Nutr Diet. 2017;30(4):515\u201323.","journal-title":"J Hum Nutr Diet"},{"key":"1391_CR19","first-page":"497","volume":"45","author":"M Dermirkol","year":"2001","unstructured":"Dermirkol M, Gokcay G, Kuru N, Donmez S, Baykal T, Seckin Y. Feasibility of breastfeeding in inborn errors of metabolism: experience in phenylketonuria. Ann Nutr Metab. 2001;45:497\u20138.","journal-title":"Ann Nutr Metab"},{"issue":"2\u20133","key":"1391_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10545-006-0332-x","volume":"29","author":"A MacDonald","year":"2006","unstructured":"MacDonald A, Depondt E, Evans S, Daly A, Hendriksz C, Chakrapani AA, et al. Breast feeding in IMD. J Inherit Metab Dis. 2006;29(2\u20133):299\u2013303.","journal-title":"J Inherit Metab Dis"},{"issue":"432","key":"1391_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1651-2227.1999.tb01151.x","volume":"88","author":"K Motzfeldt","year":"1999","unstructured":"Motzfeldt K, Lilje R, Nylander G. Breastfeeding in phenylketonuria. Acta Paediatr Suppl. 1999;88(432):25\u20137.","journal-title":"Acta Paediatr Suppl"},{"key":"1391_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ymgmr.2018.07.008","volume":"16","author":"A Pinto","year":"2018","unstructured":"Pinto A, Adams S, Ahring K, Allen H, Almeida MF, Garcia-Arenas D, et al. Early feeding practices in infants with phenylketonuria across Europe. Mol Genet Metab Rep. 2018;16:82\u20139.","journal-title":"Mol Genet Metab Rep."},{"issue":"5","key":"1391_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00431-003-1182-2","volume":"162","author":"M van Rijn","year":"2003","unstructured":"van Rijn M, Bekhof J, Dijkstra T, Smit PG, Moddermam P, van Spronsen FJ. A different approach to breast-feeding of the infant with phenylketonuria. Eur J Pediatr. 2003;162(5):323\u20136.","journal-title":"Eur J Pediatr"},{"issue":"3","key":"1391_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/nu11030529","volume":"11","author":"S Evans","year":"2019","unstructured":"Evans S, Daly A, Wildgoose J, Cochrane B, Chahal S, Ashmore C, et al. How does feeding development and progression onto solid foods in PKU compare with non-PKU children during weaning? Nutrients. 2019;11(3):529.","journal-title":"Nutrients"},{"key":"1391_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-277X.1997.00050.x","volume":"10","author":"A MacDonald","year":"1997","unstructured":"MacDonald A, Rylance G, Asplin D, Hall SK, Harris G, Booth IW. Abnormal feeding behaviours in phenylketonuria. J Hum Nut Diet. 1997;10:163\u201370.","journal-title":"J Hum Nut Diet"},{"issue":"3","key":"1391_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/jhn.12510","volume":"31","author":"S Evans","year":"2018","unstructured":"Evans S, Daly A, MacDonald J, Pinto A, MacDonald A. Fifteen years of using a second stage protein substitute for weaning in phenylketonuria: a retrospective study. J Hum Nutr Diet. 2018;31(3):349\u201356.","journal-title":"J Hum Nutr Diet"},{"issue":"6","key":"1391_CR27","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3945\/jn.114.206268","volume":"145","author":"HJ Bergmeier","year":"2015","unstructured":"Bergmeier HJ, Skouteris H, Haycraft E, Haines J, Hooley M. Reported and observed controlling feeding practices predict child eating behavior after 12 months. J Nutr. 2015;145(6):1311\u20136.","journal-title":"J Nutr"},{"key":"1391_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ymgmr.2017.10.007","volume":"14","author":"S Evans","year":"2018","unstructured":"Evans S, Daly A, Chahal S, Ashmore C, MacDonald J, MacDonald A. The influence of parental food preference and neophobia on children with phenylketonuria (PKU). Mol Genet Metab Rep. 2018;14:10\u20134.","journal-title":"Mol Genet Metab Rep."},{"issue":"4","key":"1391_CR29","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/jhn.12346","volume":"29","author":"S Evans","year":"2016","unstructured":"Evans S, Daly A, Chahal S, MacDonald J, MacDonald A. Food acceptance and neophobia in children with phenylketonuria: a prospective controlled study. J Hum Nutr Diet. 2016;29(4):427\u201333.","journal-title":"J Hum Nutr Diet"},{"issue":"1","key":"1391_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.appet.2012.09.014","volume":"60","author":"GL Mitchell","year":"2013","unstructured":"Mitchell GL, Farrow C, Haycraft E, Meyer C. Parental influences on children\u2019s eating behaviour and characteristics of successful parent-focussed interventions. Appetite. 2013;60(1):85\u201394.","journal-title":"Appetite."},{"issue":"6","key":"1391_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1515\/jpem-2018-0492","volume":"32","author":"JC Rocha","year":"2019","unstructured":"Rocha JC, van Dam E, Ahring K, Almeida MF, Belanger-Quintana A, Dokoupil K, et al. A series of three case reports in patients with phenylketonuria performing regular exercise: first steps in dietary adjustment. J Pediatr Endocrinol Metab. 2019;32(6):635\u201341.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1391_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ymgmr.2015.10.003","volume":"5","author":"PN Mazzola","year":"2015","unstructured":"Mazzola PN, Teixeira BC, Schirmbeck GH, Reischak-Oliveira A, Derks TGJ, van Spronsen FJ, et al. Acute exercise in treated phenylketonuria patients: physical activity and biochemical response. Mol Genet Metab Rep. 2015;5:55\u20139.","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"1391_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10545-007-0436-y","volume":"30","author":"F Maillot","year":"2007","unstructured":"Maillot F, Cook P, Lilburn M, Lee PJ. A practical approach to maternal phenylketonuria management. J Inherit Metab Dis. 2007;30(2):198\u2013201.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"1391_CR34","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.mcna.2016.06.004","volume":"100","author":"MA Kominiarek","year":"2016","unstructured":"Kominiarek MA, Rajan P. Nutrition recommendations in pregnancy and lactation. Med Clin North Am. 2016;100(6):1199\u2013215.","journal-title":"Med Clin North Am"},{"issue":"1","key":"1391_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2019.04.004","volume":"127","author":"AC Muntau","year":"2019","unstructured":"Muntau AC, Adams DJ, Belanger-Quintana A, Bushueva TV, Cerone R, Chien YH, et al. International best practice for the evaluation of responsiveness to sapropterin dihydrochloride in patients with phenylketonuria. Mol Genet Metab. 2019;127(1):1\u201311.","journal-title":"Mol Genet Metab"},{"issue":"6","key":"1391_CR36","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s10545-012-9491-0","volume":"35","author":"R Teissier","year":"2012","unstructured":"Teissier R, Nowak E, Assoun M, Mention K, Cano A, Fouilhoux A, et al. Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation. J Inherit Metab Dis. 2012;35(6):993\u20139.","journal-title":"J Inherit Metab Dis"}],"updated-by":[{"DOI":"10.1186\/s13023-020-01486-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01391-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-020-01391-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-020-01391-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T19:12:38Z","timestamp":1628017958000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-020-01391-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,4]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1391"],"URL":"https:\/\/doi.org\/10.1186\/s13023-020-01391-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,4]]},"assertion":[{"value":"9 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via the original article.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KA has been a member of the European Nutrition Expert Panel (Merck Serono international, Biomarin).ABQ has been a board member and consultant for BioMarin and Merck Serono, received grants from BioMarin and received honoraria as a consultant and\/or speaker and travel support from BioMarin, Merck, Nutricia, Vitaflo, and Mead-Johnson.SB has received research grants from Nutricia Metabolics, Nutricia GmbH Germany and Merck Serono GmbH.AB has been a member of Scientific Advisory Boards of Merck-Serono SA, Biomarin, Nutricia and has received honoraria from Merck-Serono SA, Biomarin, Nutricia\/Danone.JC has received honoraria as a consultant and\/or speaker from Merck-Serono SA and Nutricia\/Danone.TC has been a consultant for Biomarin and has received honoraria as a consultant and\/or speaker and travel support from BioMarin.MG has been a member of the Scientific Advisory Board of Merck-Serono SA, and Biomarin and received honoraria as a consultant and\/or speaker for Merck Serono SA and Nutricia.FF has been a board member for BioMarin and received honoraria as a consultant and\/or speaker and travel support from BioMarin, Genzyme, Merck-Serono, Nutricia and Vitaflo.CEMH\u2019s institution has received financial support for registries for Gaucher disease and Fabry disease and for participation in premarketing studies from Genzyme and Protalix.SCJH has participated in strategic advisory boards and received honoraria as a consultant and\/or speaker for Merck Serono SA, Biomarin and Nutricia.AM has been a member of the European Nutritionist Expert Panel Biomarin, Sapropterin Advisory Board Biomarin, the advisory board ELEMENT Danone-Nutricia, the advisory board for Arla and Applied Pharma Research, and received research funding and honoraria from Nutricia, Vitaflo International and Merck Serono.FM has received honoraria as a consultant and\/or speaker from Merck Serono SA, Nutricia and Arla Foods.ACM has been a board member and consultant for BioMarin, Merck, Arla Food, Applied Pharma Research, and Nestl\u00e9, received grants from Nutricia and Vitaflo, and received honoraria as a consultant and\/or speaker from BioMarin, Merck, Nestl\u00e9, and Actelion.JCR has been a member of the European Nutritionist Expert Panel [Biomarin], the Advisory Board for Applied Pharma Research s.a. and Nutricia, and received honoraria as a speaker from APR, Merck Serono, Biomarin, Nutricia, Vitaflo and Cambrooke.FJvS has been a member of scientific advisory boards for defects in amino acid metabolism of APR, Arla Food International, BioMarin, Eurocept Int, Lucana, Moderna TX, Nutricia, Rivium and SoBi, has received research grants from Alexion, Biomarin, Codexis, Nutricia, SoBi, and Vitaflo, has received grants from patient organizations ESPKU, Metakids, NPKUA, Stofwisselkracht, Stichting PKU research and Tyrosinemia Foundation, and has received honoraria as consultant and speaker from APR, Biomarin, MendeliKABS and Nutricia.FT received grants from Vitaflo Germany and honoraria as a speaker from Merck-Serono SA.AMJvW has received a research grant from Nutricia, honoraria from Biomarin as speaker, and travel support from Nutricia and Vitaflo.The other authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}